The company's shares could soar in the next year, provided several things go its way. Investing in penny stocks -- companies ...

University of Kentucky Markey Cancer Center researcher Weisi Yan, M.D., Ph.D., recently shared his work on radiation therapy ...

This study provides valuable findings regarding potential correlates of protection against the African swine fever virus. The evidence supporting the claims is solid, although analysis using a higher ...

During a live event, Barbara T. Ma, MD, MS, reviewed guidelines on management and best practices for the use of ...

Columnist Leigh Anne Nelson rethinks her MS medication, discovering a risk and navigating crucial treatment decisions with ...

The primary endpoint was functional immune tolerance, defined as off all immunosuppressive drugs 24 months after ...

Oncolytics Biotech® Inc. (NASDAQ: ONCY) (TSX: ONC), a leading clinical-stage company specializing in immunotherapy for ...

(NASDAQ: IOVA), a commercial biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today ...

Higher scores on a dietary index linked to gut microbiota health are associated with slower biological aging in US adults, according to a large cross-sectional NHANES study. The findings suggest that ...

Anixa Biosciences' breast cancer vaccine elicited targeted immune responses in 70% of patients. Click here to read an ...

EXCLUSIVE: A 20-year study in the US and UK has created an online calculator that can forecast if a rare cancer will made a comeback.

During a live event, Jorge Monge, MD, discussed short and long-term adverse events associated with CAR T-cell therapy in ...